Shares of Electromed, Inc. (NYSEAMERICAN:ELMD) rose 6.1% during trading on Friday . The company traded as high as $11.37 and last traded at $10.96, approximately 127,504 shares were traded during mid-day trading. An increase of 169% from the average daily volume of 47,445 shares. The stock had previously closed at $10.33.
ELMD has been the subject of a number of recent analyst reports. Zacks Investment Research cut Electromed from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. Dougherty & Co initiated coverage on Electromed in a research note on Friday, October 18th. They issued a “buy” rating and a $12.00 price target for the company. Finally, TheStreet raised Electromed from a “c+” rating to a “b-” rating in a research note on Monday, November 18th.
Electromed (NYSEAMERICAN:ELMD) last released its quarterly earnings data on Tuesday, February 11th. The medical equipment provider reported $0.14 EPS for the quarter, beating the consensus estimate of $0.04 by $0.10. The company had revenue of $8.55 million during the quarter.
Electromed Company Profile (NYSEAMERICAN:ELMD)
Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality.
Recommended Story: What are the benefits of a balanced fund?
Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.